| Trial ID: | L7064 |
| Source ID: | NCT00913497
|
| Associated Drug: |
Insulin Glulisine
|
| Title: |
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00913497/results
|
| Conditions: |
Type 1 Diabetes Mellitus
|
| Interventions: |
DRUG: insulin glulisine|DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Difference in the Two Hour and Four Hour Post Prandial Blood Glucose Levels Following Administration of Insulin Glulisine Versus Insulin Aspart at the End of the Twenty Study Days, Compare average blood glucose at 2 and 4 hours post prandial minus blood glucose at baseline (prior to eating), measured daily at baseline, 2 and 4 hours post prandial for 20 days | Secondary: Occurrence of Hypoglycemia;, measured daily at 2 and 4 hours postprandial for 20 days
|
| Sponsor/Collaborators: |
Sponsor: Spectrum Health Hospitals | Collaborators: Helen DeVos Children's Hospital
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
PHASE4
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-06
|
| Completion Date: |
2012-01
|
| Results First Posted: |
2023-09-18
|
| Last Update Posted: |
2023-09-18
|
| Locations: |
Helen DeVos Childrens Hospital, Grand Rapids, Michigan, 49503, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00913497
|
